The anticancer agent cisplatin encapsulated in sterically stabilized liposomes is studied with extended X-ray absorption fine structure (EXAFS) method. Analysis of local atomic structure around Pt atoms clearly indicates that the liposome-encapsulated drug is chemically stable and does not hydrolyze. Cisplatin forms a supersaturated solution in the liposome interior at a concentration about eight-fold above its aqueous solubility. 相似文献
We deal with MAXH0-FREE PARTIAL SUBGRAPH. We mainly prove that 3-locally optimum solutions achieve approximation ratio (δ0+1)/(B+2+ν0), where B=maxv∈VdG(v), δ0=minv∈V(H0)dH0(v) and ν0=(|V(H0)|+1)/δ0. Next, we show that this ratio rises up to 3/(B+1) when H0=K3. Finally, we provide hardness results for MAXK3-FREE PARTIAL SUBGRAPH. 相似文献
The main purpose of this paper is to use a mean value theorem of Dirichlet L-functions to study the asymptotic property of a hybrid mean value of a generalized Cochrane sum, and give an interesting mean value formula.2000 Mathematics Subject Classification: Primary—11F20; Secondary—11F99 相似文献
In this paper we describe the design and manufacture of an axial-torsion test specimen, and provide relationships needed when
conducting stress-strain characterization experiments with the specimen. The specimen is a short hollow cylinder of rubber
bonded between two steel mounting rings, in which simultaneous axial and shear strains are produced via independently controlled
axial and twist displacements. We present calculations for the strain-displacement and stress-load relationships, and strain
energy density. These relationships have been established and validated via a combination of analytical and experimental techniques,
and finite element analysis. We have investigated the extent and effects of strain and stress field non-uniformity in the
test specimen. The specimen design is sufficiently simple that a closed-form expression for the strain-displacement relationship
has been successfully developed. 相似文献
Cancer immunotherapy aims at stimulating the immune system to react against cancer stealth capabilities. It consists of repeatedly injecting small doses of a tumor-associated molecule one wants the immune system to recognize, until a consistent immune response directed against the tumor cells is observed.
We have applied the theory of optimal control to the problem of finding the optimal schedule of injections of an immunotherapeutic agent against cancer. The method employed works for a general ODE system and can be applied to find the optimal protocol in a variety of clinical problems where the kinetics of the drug or treatment and its influence on the normal physiologic functions have been described by a mathematical model.
We show that the choice of the cost function has dramatic effects on the kind of solution the optimization algorithm is able to find. This provides evidence that a careful ODE model and optimization schema must be designed by mathematicians and clinicians using their proper different perspectives. 相似文献